MITROJA-30

MRP

MRP 230/-Strip

Description

• Each uncoated orally disintegrating tablet contains : Mitrojapine IP 30mg  Excipients q.s.

Doses

• As directed by the Physician

Indication

• Mirtazapine is an atypical antidepressant and is used primarily for the treatment of a major depressive disorder. Mirtazapine is in a group of tetracyclic antidepressants (TeCA). Mirtazapine inhibits the central presynaptic alpha-2-adrenergic receptors, which causes an increased release of serotonin and norepinephrine.